In 67 adults with minimal change disease, lower-dose prednisolone plus alfacalcidol failed non-inferiority vs high-dose prednisolone for remission (88% vs 91%), but cut cumulative prednisolone (3.7 g vs 8.0 g), serious adverse events and glucocorticoid toxicity.
RCTn = 67
Kristensen et al. A randomized controlled non-inferiority trial examined lower dose prednisolone and activated vitamin D in adult minimal change podocytopathy